Abstract
Cotazym-S-Forte, a new pancreatic supplement containing 10,000 BP units of lipase activity per capsule, was compared with a standard dose pancreatin supplement (Pancrease) with 5000 BP units lipase activity in a randomised crossover trial. The number of capsules of Cotazym-S-Forte administered was half the usual number of Pancrease capsules and was associated with the same degree of fat absorption as Pancrease.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Graham D. Y. Ins and outs of pancreatic enzymes and adjuvant therapies. J Pediatr Gastroenterol Nutr. 1984;3 (Suppl 1):S120–S126. doi: 10.1097/00005176-198400031-00019. [DOI] [PubMed] [Google Scholar]
- Wong L. T., Turtle S., Davidson A. G. Secretin pancreozymin stimulation test and confirmation of the diagnosis of cystic fibrosis. Gut. 1982 Sep;23(9):744–750. doi: 10.1136/gut.23.9.744. [DOI] [PMC free article] [PubMed] [Google Scholar]